Bausch & Lomb Corp
corporate_fare Company Profile
Bausch & Lomb Corp (NYSE:BLCO) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 16 items for BLCO at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-19, rated 7/10. Across its 16 most recent items scored 7 or higher, the top rating is 8/10, with 9 rated 8 or above. Recent SEC coverage for BLCO spans 10-Q, 8-K, 8-K/A, DEF 14A.
Recent high-impact activity:
- BL1332 Phase 2 Misses Primary Endpoint, Clouding Path to Phase 3
- Bausch + Lomb 10-Q: Q3 Net Income $32M, Nine-Month Operating Income Jumps to $271M
- Bausch + Lomb Beats on Q3, Raises 2026 Revenue and EBITDA Guidance
- Q3 Revenue Climbs 7% to $1.38B as Bausch + Lomb Swings to $32M Profit
- Bausch + Lomb CEO Brent Saunders Exits With $75.5M Severance; Company Raises 2026 Guidance
Financial Snapshot
Short Interest & Short Volume
2.28 days to coverFINRA reported short interest of 2,590,201 shares in BLCO as of the October 30, 2026 settlement, a 1.9% increase from the prior period — about 2.3 days to cover at its recent average daily volume. On November 20, 2026, 56.4% of BLCO volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.